NYSE - Nasdaq Real Time Price • USD
Quest Diagnostics Incorporated (DGX)
As of 12:52 PM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 16 | 16 | 17 | 17 |
| Avg. Estimate | 1.85 | 2.35 | 8.75 | 9.41 |
| Low Estimate | 1.82 | 2.22 | 8.7 | 9.13 |
| High Estimate | 1.9 | 2.42 | 8.8 | 9.58 |
| Year Ago EPS | 2.04 | 2.3 | 8.71 | 8.75 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 14 | 14 | 16 | 16 |
| Avg. Estimate | 2.29B | 2.39B | 9.4B | 9.73B |
| Low Estimate | 2.26B | 2.38B | 9.37B | 9.6B |
| High Estimate | 2.32B | 2.42B | 9.42B | 9.9B |
| Year Ago Sales | 2.33B | 2.25B | 9.25B | 9.4B |
| Sales Growth (year/est) | -1.90% | 6.20% | 1.60% | 3.50% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 1.97 | 2.27 | 2.19 | 2.11 |
| EPS Actual | 2.04 | 2.3 | 2.22 | 2.15 |
| Difference | 0.07 | 0.03 | 0.03 | 0.04 |
| Surprise % | 3.60% | 1.30% | 1.40% | 1.90% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 1.85 | 2.35 | 8.75 | 9.41 |
| 7 Days Ago | 1.85 | 2.35 | 8.75 | 9.41 |
| 30 Days Ago | 1.85 | 2.36 | 8.75 | 9.41 |
| 60 Days Ago | 1.85 | 2.37 | 8.75 | 9.42 |
| 90 Days Ago | 2.07 | 2.29 | 9.01 | 9.71 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | 1 | -- |
| Up Last 30 Days | 2 | 1 | 2 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | 1 | 1 | 1 |
Growth Estimates
| CURRENCY IN USD | DGX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -9.30% | -- | -- | 1.30% |
| Next Qtr. | 2.20% | -- | -- | 10.60% |
| Current Year | 0.50% | -- | -- | 5.10% |
| Next Year | 7.50% | -- | -- | 13.40% |
| Next 5 Years (per annum) | 5.21% | -- | -- | 11.21% |
| Past 5 Years (per annum) | 9.96% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | Truist Securities: Hold to Hold | 3/20/2024 |
| Initiated | Leerink Partners: Market Perform | 2/26/2024 |
| Upgrade | Jefferies: Hold to Buy | 2/7/2024 |
| Maintains | Truist Securities: Hold to Hold | 2/2/2024 |
| Maintains | Truist Securities: Hold to Hold | 12/20/2023 |
| Upgrade | B of A Securities: Neutral to Buy | 12/12/2023 |
Related Tickers
LH Laboratory Corporation of America Holdings
207.02
+1.95%
ICLR ICON Public Limited Company
304.66
+2.26%
IQV IQVIA Holdings Inc.
235.92
+1.98%
CRL Charles River Laboratories International, Inc.
240.54
+3.43%
DHR Danaher Corporation
253.54
+7.40%
A Agilent Technologies, Inc.
139.40
+4.10%
MEDP Medpace Holdings, Inc.
403.41
+7.22%
WAT Waters Corporation
314.77
+5.19%
TMO Thermo Fisher Scientific Inc.
575.68
+4.98%
IDXX IDEXX Laboratories, Inc.
489.84
+2.14%